Free Cash Flow to The Firm (FCFF)
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
The financial performance from 2017 to 2022 indicates a strong upward trajectory in both operating cash generation and free cash flow to the firm (FCFF). Although minor fluctuations occurred in 2018 and 2020, the overall trend reflects a significant expansion in the company's capacity to generate cash available to all capital providers.
- Operating Cash Flow Trends
- Net cash provided by operating activities grew from 1,504,138 thousand USD in 2017 to 2,703,088 thousand USD in 2022. A notable acceleration occurred in 2019, where cash flow increased by approximately 66% over the previous year. Despite a slight contraction in 2020, the metric recovered and maintained a steady increase through 2022.
- Free Cash Flow to the Firm (FCFF) Analysis
- FCFF exhibited a substantial increase over the six-year period, rising from 1,087,485 thousand USD in 2017 to 2,380,779 thousand USD in 2022. The most significant growth spike was observed between 2018 and 2019, with FCFF increasing by approximately 81%. This suggests a period of high operational efficiency or reduced capital intensity during that timeframe.
- Cash Flow Conversion and Investment Patterns
- The variance between operating cash flow and FCFF indicates the scale of capital expenditures and adjustments. This gap narrowed significantly in 2018 and 2019 before widening slightly from 2020 through 2022, moving from 236,564 thousand USD in 2020 to 322,309 thousand USD in 2022. This suggests a gradual increase in capital reinvestment in the latter part of the period.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Interest Paid, Net of Tax
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
2 2022 Calculation
Interest paid, tax = Interest paid × EITR
= 219,800 × 23.70% = 52,093
Financial analysis reveals a significant overall increase in interest paid net of tax over the six-year period, though the progression was marked by distinct fluctuations in both expenditure and the applicable tax rate.
- Net Interest Expenditure Patterns
- Interest payments net of tax grew from 49,744 thousand US$ in 2017 to a peak of 167,707 thousand US$ in 2022. A substantial increase was noted between 2017 and 2019, followed by a temporary contraction in 2020 to 96,749 thousand US$, before returning to a growth phase through 2022.
- Effective Income Tax Rate Fluctuations
- The effective income tax rate demonstrated high variability, decreasing from 60.30% in 2017 to a period low of 11.70% in 2019. This was followed by a recovery to 35.80% in 2020 and a subsequent gradual decline to 23.70% by 2022.
- Relationship Between Tax Rates and Interest Cost
- The expansion of net interest costs from 2017 to 2019 occurred despite a sharp decline in the effective income tax rate. This suggests that the increase in gross interest obligations significantly outweighed the reduction in the tax shield. The peak net expenditure in 2022 coincided with a relatively moderate tax rate of 23.70%.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Enterprise Value to FCFF Ratio, Current
| Selected Financial Data (US$ in thousands) | |
| Enterprise value (EV) | 41,299,807) |
| Free cash flow to the firm (FCFF) | 2,380,779) |
| Valuation Ratio | |
| EV/FCFF | 17.35 |
| Benchmarks | |
| EV/FCFF, Competitors1 | |
| Abbott Laboratories | 25.75 |
| Elevance Health Inc. | 20.49 |
| Intuitive Surgical Inc. | 62.87 |
| Medtronic PLC | 25.42 |
| UnitedHealth Group Inc. | 20.98 |
| EV/FCFF, Sector | |
| Health Care Equipment & Services | 20.11 |
| EV/FCFF, Industry | |
| Health Care | 27.54 |
Based on: 10-K (reporting date: 2022-09-30).
1 Click competitor name to see calculations.
If the company EV/FCFF is lower then the EV/FCFF of benchmark then company is relatively undervalued.
Otherwise, if the company EV/FCFF is higher then the EV/FCFF of benchmark then company is relatively overvalued.
Enterprise Value to FCFF Ratio, Historical
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Enterprise value (EV)1 | 36,473,156) | 30,235,610) | 20,514,111) | 18,995,014) | 20,769,340) | 18,335,740) | |
| Free cash flow to the firm (FCFF)2 | 2,380,779) | 2,361,584) | 1,970,476) | 2,182,910) | 1,205,463) | 1,087,485) | |
| Valuation Ratio | |||||||
| EV/FCFF3 | 15.32 | 12.80 | 10.41 | 8.70 | 17.23 | 16.86 | |
| Benchmarks | |||||||
| EV/FCFF, Competitors4 | |||||||
| Abbott Laboratories | 23.24 | 23.47 | — | — | — | — | |
| Elevance Health Inc. | 13.32 | 12.74 | — | — | — | — | |
| Intuitive Surgical Inc. | 85.45 | 56.01 | — | — | — | — | |
| Medtronic PLC | 20.32 | 33.84 | — | — | — | — | |
| UnitedHealth Group Inc. | 19.30 | 22.21 | — | — | — | — | |
| EV/FCFF, Sector | |||||||
| Health Care Equipment & Services | 20.44 | 23.51 | — | — | — | — | |
| EV/FCFF, Industry | |||||||
| Health Care | 18.66 | 17.80 | — | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
3 2022 Calculation
EV/FCFF = EV ÷ FCFF
= 36,473,156 ÷ 2,380,779 = 15.32
4 Click competitor name to see calculations.
The Enterprise Value to Free Cash Flow to the Firm (EV/FCFF) ratio exhibits a non-linear trajectory between 2017 and 2022, characterized by an initial contraction followed by a sustained period of expansion. While the ratio began the period at 16.86, it experienced a significant decline to a trough of 8.70 in 2019 before trending upward to close at 15.32 in 2022.
- Enterprise Value (EV) Trends
- Enterprise value remained relatively stable between 2017 and 2020, fluctuating within a range of approximately 18.3 billion to 20.7 billion US dollars. However, a sharp acceleration in value is observed starting in 2021, with EV rising to 30.2 billion and further increasing to 36.4 billion by September 30, 2022. This represents a substantial increase in the overall market valuation of the firm's operations in the latter part of the analyzed period.
- Free Cash Flow to the Firm (FCFF) Performance
- FCFF demonstrates a general upward trend over the six-year horizon. A notable surge occurred in 2019, where FCFF increased from 1.2 billion to 2.18 billion US dollars, nearly doubling in a single year. Following this spike, the cash flow remained relatively resilient, stabilizing and slightly growing to reach 2.38 billion US dollars by 2022.
- EV/FCFF Ratio Interpretation
- The sharp decrease in the EV/FCFF ratio in 2019 was primarily driven by the rapid expansion of FCFF while the enterprise value remained constant. This led to a valuation low of 8.70, suggesting a period where the firm was generating significantly more cash flow relative to its market value. From 2020 onward, the ratio increased annually, moving from 10.41 to 15.32. This recovery is attributed to the enterprise value growing at a faster pace than the incremental gains in free cash flow, indicating an increase in the multiple the market was willing to pay for each dollar of FCFF.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?